{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:09:22Z","timestamp":1792469362538,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T00:00:00Z","timestamp":1299801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s12016-011-8265-z","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T04:08:52Z","timestamp":1299730132000},"page":"31-38","source":"Crossref","is-referenced-by-count":99,"title":["The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension"],"prefix":"10.1007","volume":"44","author":[{"given":"Nada","family":"Kherbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu C.","family":"Tamby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bussone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanadi","family":"Dib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,11]]},"reference":[{"key":"8265_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","volume":"336","author":"LJ Rubin","year":"1997","unstructured":"Rubin LJ (1997) Primary pulmonary hypertension. N Engl J Med 336:111\u2013117","journal-title":"N Engl J Med"},{"key":"8265_CR2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","volume":"54","author":"G Simonneau","year":"2009","unstructured":"Simonneau G, Robbins IM, Beghetti M et al (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:S43\u2013S54","journal-title":"J Am Coll Cardiol"},{"key":"8265_CR3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","volume":"62","author":"D Mukerjee","year":"2003","unstructured":"Mukerjee D, St George D, Coleiro B et al (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62:1088\u20131093","journal-title":"Ann Rheum Dis"},{"key":"8265_CR4","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","volume":"52","author":"E Hachulla","year":"2005","unstructured":"Hachulla E, Gressin V, Guillevin L et al (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52:3792\u20133800","journal-title":"Arthritis Rheum"},{"key":"8265_CR5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1164\/rccm.200909-1331PP","volume":"181","author":"J Pavec Le","year":"2010","unstructured":"Le Pavec J, Humbert M, Mouthon L, Hassoun PM (2010) Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 181:1285\u20131293","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","volume":"67","author":"Z Deng","year":"2000","unstructured":"Deng Z, Morse JH, Slager SL et al (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67:737\u2013744","journal-title":"Am J Hum Genet"},{"key":"8265_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","volume":"345","author":"RC Trembath","year":"2001","unstructured":"Trembath RC, Thomson JR, Machado RD et al (2001) Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345:325\u2013334","journal-title":"N Engl J Med"},{"key":"8265_CR8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2003.11890","volume":"59","author":"A Chaouat","year":"2004","unstructured":"Chaouat A, Coulet F, Favre C et al (2004) Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Thorax 59:446\u2013448","journal-title":"Thorax"},{"key":"8265_CR9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","volume":"22","author":"P Dorfmuller","year":"2003","unstructured":"Dorfmuller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22:358\u2013363","journal-title":"Eur Respir J"},{"key":"8265_CR10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1183\/09031936.05.00045705","volume":"26","author":"MR Nicolls","year":"2005","unstructured":"Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF (2005) Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 26:1110\u20138","journal-title":"Eur Respir J"},{"key":"8265_CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7326\/0003-4819-119-1-199307010-00008","volume":"119","author":"DB Badesch","year":"1993","unstructured":"Badesch DB, Wynne KM, Bonvallet S, Voelkel NF, Ridgway C, Groves BM (1993) Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann Intern Med 119:44\u201346","journal-title":"Ann Intern Med"},{"key":"8265_CR12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby MC, Chanseaud Y, Humbert M et al (2005) Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60:765\u2013772","journal-title":"Thorax"},{"key":"8265_CR13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","volume":"28","author":"MC Tamby","year":"2006","unstructured":"Tamby MC, Humbert M, Guilpain P et al (2006) Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension. Eur Respir J 28:799\u2013807","journal-title":"Eur Respir J"},{"key":"8265_CR14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","volume":"177","author":"B Terrier","year":"2008","unstructured":"Terrier B, Tamby MC, Camoin L et al (2008) Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med 177:1128\u20131134","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.2106007","volume":"165","author":"K Balabanian","year":"2002","unstructured":"Balabanian K, Foussat A, Dorfmuller P et al (2002) CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 165:1419\u20131425","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1183\/09031936.03.00006903","volume":"22","author":"TM Bull","year":"2003","unstructured":"Bull TM, Cool CD, Serls AE et al (2003) Primary pulmonary hypertension, Castleman\u2019s disease and human herpesvirus-8. Eur Respir J 22:403\u2013407","journal-title":"Eur Respir J"},{"key":"8265_CR17","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","volume":"54","author":"PM Hassoun","year":"2009","unstructured":"Hassoun PM, Mouthon L, Barbera JA et al (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54:S10\u2013S19","journal-title":"J Am Coll Cardiol"},{"key":"8265_CR18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","volume":"151","author":"M Humbert","year":"1995","unstructured":"Humbert M, Monti G, Brenot F et al (1995) Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151:1628\u20131631","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1164\/ajrccm.157.3.9707095","volume":"157","author":"P Lesprit","year":"1998","unstructured":"Lesprit P, Godeau B, Authier FJ et al (1998) Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am J Respir Crit Care Med 157:907\u2013911","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-10-6","volume":"10","author":"L Savale","year":"2009","unstructured":"Savale L, Tu L, Rideau D et al (2009) Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 10:6","journal-title":"Respir Res"},{"key":"8265_CR21","first-page":"126","volume":"1","author":"A Bhargava","year":"1999","unstructured":"Bhargava A, Kumar A, Yuan N, Gewitz MH, Mathew R (1999) Monocrotaline induces interleukin-6 mRNA expression in rat lungs. Heart Dis 1:126\u2013132","journal-title":"Heart Dis"},{"key":"8265_CR22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2169\/internalmedicine.46.6262","volume":"46","author":"M Matsuyama","year":"2007","unstructured":"Matsuyama M, Suzuki T, Tsuboi H et al (2007) Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman\u2019s disease. Intern Med 46:771\u2013774","journal-title":"Intern Med"},{"key":"8265_CR23","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","volume":"112","author":"N Nishimoto","year":"2008","unstructured":"Nishimoto N, Terao K, Mima T, Nakahara H, Takagi N, Kakehi T (2008) Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood 112:3959\u20133964","journal-title":"Blood"},{"key":"8265_CR24","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","volume":"116","author":"SN Song","year":"2010","unstructured":"Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K (2010) Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood 116:3627\u20133634","journal-title":"Blood"},{"key":"8265_CR25","doi-asserted-by":"crossref","first-page":"720305","DOI":"10.1155\/2010\/720305","volume":"2010","author":"Y Furuya","year":"2010","unstructured":"Furuya Y, Satoh T, Kuwana M (2010) Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int J Rheumatol 2010:720305","journal-title":"Int J Rheumatol"},{"key":"8265_CR26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.00104706","volume":"29","author":"F Perros","year":"2007","unstructured":"Perros F, Dorfmuller P, Souza R et al (2007) Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. Eur Respir J 29:937\u2013943","journal-title":"Eur Respir J"},{"key":"8265_CR27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","volume":"176","author":"O Sanchez","year":"2007","unstructured":"Sanchez O, Marcos E, Perros F et al (2007) Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 176:1041\u20131047","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00408-010-9232-9","volume":"188","author":"GA Heresi","year":"2010","unstructured":"Heresi GA, Aytekin M, Newman J, Dweik RA (2010) CXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survival. Lung 188:191\u20137","journal-title":"Lung"},{"key":"8265_CR29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","volume":"79","author":"CH Heldin","year":"1999","unstructured":"Heldin CH, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283\u20131316","journal-title":"Physiol Rev"},{"key":"8265_CR30","first-page":"L100","volume":"264","author":"D Katayose","year":"1993","unstructured":"Katayose D, Ohe M, Yamauchi K et al (1993) Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am J Physiol 264:L100\u2013L106","journal-title":"Am J Physiol"},{"key":"8265_CR31","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.1073\/pnas.89.21.10385","volume":"89","author":"MI Hertz","year":"1992","unstructured":"Hertz MI, Henke CA, Nakhleh RE et al (1992) Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci USA 89:10385\u201310389","journal-title":"Proc Natl Acad Sci USA"},{"key":"8265_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","volume":"178","author":"F Perros","year":"2008","unstructured":"Perros F, Montani D, Dorfmuller P et al (2008) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178:81\u201388","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR33","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E, Ghofrani HA et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811\u20132821","journal-title":"J Clin Invest"},{"key":"8265_CR34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.105.540542","volume":"112","author":"SL Merklinger","year":"2005","unstructured":"Merklinger SL, Jones PL, Martinez EC, Rabinovitch M (2005) Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 112:423\u2013431","journal-title":"Circulation"},{"key":"8265_CR35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/01.RES.79.6.1131","volume":"79","author":"PL Jones","year":"1996","unstructured":"Jones PL, Rabinovitch M (1996) Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res 79:1131\u20131142","journal-title":"Circ Res"},{"key":"8265_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1083\/jcb.139.1.279","volume":"139","author":"PL Jones","year":"1997","unstructured":"Jones PL, Crack J, Rabinovitch M (1997) Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139:279\u2013293","journal-title":"J Cell Biol"},{"key":"8265_CR37","first-page":"275","volume":"144","author":"RM Tuder","year":"1994","unstructured":"Tuder RM, Groves B, Badesch DB, Voelkel NF (1994) Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 144:275\u2013285","journal-title":"Am J Pathol"},{"key":"8265_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1465-9921-9-20","volume":"9","author":"S Ulrich","year":"2008","unstructured":"Ulrich S, Taraseviciene-Stewart L, Huber LC, Speich R, Voelkel N (2008) Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study. Respir Res 9:20","journal-title":"Respir Res"},{"key":"8265_CR39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0896-8411(03)00121-5","volume":"21","author":"JC Crispin","year":"2003","unstructured":"Crispin JC, Martinez A, Alcocer-Varela J (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 21:273\u2013276","journal-title":"J Autoimmun"},{"key":"8265_CR40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0300-9475.2004.01370.x","volume":"59","author":"MF Liu","year":"2004","unstructured":"Liu MF, Wang CR, Fung LL, Wu CR (2004) Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59:198\u2013202","journal-title":"Scand J Immunol"},{"key":"8265_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1521-6616(03)00062-7","volume":"108","author":"F Ingegnoli","year":"2003","unstructured":"Ingegnoli F, Trabattoni D, Saresella M, Fantini F, Clerici M (2003) Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis. Clin Immunol 108:21\u201328","journal-title":"Clin Immunol"},{"key":"8265_CR42","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.4049\/jimmunol.167.6.3521","volume":"167","author":"O Benveniste","year":"2001","unstructured":"Benveniste O, Cherin P, Maisonobe T et al (2001) Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 167:3521\u20133529","journal-title":"J Immunol"},{"key":"8265_CR43","first-page":"726","volume":"31","author":"T Mandl","year":"2004","unstructured":"Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G (2004) CD4+ T-lymphocytopenia\u2013a frequent finding in anti-SSA antibody seropositive patients with primary Sjogren\u2019s syndrome. J Rheumatol 31:726\u2013728","journal-title":"J Rheumatol"},{"key":"8265_CR44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000111548","volume":"75","author":"S Ulrich","year":"2008","unstructured":"Ulrich S, Nicolls MR, Taraseviciene L, Speich R, Voelkel N (2008) Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration 75:272\u2013280","journal-title":"Respiration"},{"key":"8265_CR45","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00094706","volume":"29","author":"F Perros","year":"2007","unstructured":"Perros F, Dorfmuller P, Souza R et al (2007) Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension. Eur Respir J 29:462\u2013468","journal-title":"Eur Respir J"},{"key":"8265_CR46","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2222.2005.02321.x","volume":"35","author":"LS Rijt van","year":"2005","unstructured":"van Rijt LS, Lambrecht BN (2005) Dendritic cells in asthma: a function beyond sensitization. Clin Exp Allergy 35:1125\u20131134","journal-title":"Clin Exp Allergy"},{"key":"8265_CR47","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","volume":"102","author":"AK Palucka","year":"2005","unstructured":"Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J (2005) Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA 102:3372\u20133377","journal-title":"Proc Natl Acad Sci USA"},{"key":"8265_CR48","first-page":"483","volume":"3","author":"DI Gabrilovich","year":"1997","unstructured":"Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3:483\u2013490","journal-title":"Clin Cancer Res"},{"key":"8265_CR49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00041552-200011000-00004","volume":"9","author":"AE Morelli","year":"2000","unstructured":"Morelli AE, Thomson AW (2000) Role of dendritic cells in the immune response against allografts. Curr Opin Nephrol Hypertens 9:607\u2013613","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"8265_CR50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nm1097","volume":"10","author":"JR Conejo-Garcia","year":"2004","unstructured":"Conejo-Garcia JR, Benencia F, Courreges MC et al (2004) Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 10:950\u2013958","journal-title":"Nat Med"},{"key":"8265_CR51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","volume":"177","author":"O Sitbon","year":"2008","unstructured":"Sitbon O, Lascoux-Combe C, Delfraissy JF et al (2008) Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 177:108\u2013113","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e3282f7cd42","volume":"22","author":"PY Hsue","year":"2008","unstructured":"Hsue PY, Deeks SG, Farah HH et al (2008) Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension. AIDS 22:825\u2013833","journal-title":"AIDS"},{"key":"8265_CR53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bbrc.2005.05.198","volume":"333","author":"GD Kanmogne","year":"2005","unstructured":"Kanmogne GD, Primeaux C, Grammas P (2005) Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 333:1107\u20131115","journal-title":"Biochem Biophys Res Commun"},{"key":"8265_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jss.2009.02.005","volume":"156","author":"P Duffy","year":"2009","unstructured":"Duffy P, Wang X, Lin PH, Yao Q, Chen C (2009) HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res 156:257\u2013264","journal-title":"J Surg Res"},{"key":"8265_CR55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2003.01543.x","volume":"84","author":"M Toborek","year":"2003","unstructured":"Toborek M, Lee YW, Pu H et al (2003) HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J Neurochem 84:169\u2013179","journal-title":"J Neurochem"},{"key":"8265_CR56","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/rccm.200601-005OC","volume":"174","author":"JC Marecki","year":"2006","unstructured":"Marecki JC, Cool CD, Parr JE et al (2006) HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques. Am J Respir Crit Care Med 174:437\u2013445","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1183\/09031936.00014209","volume":"34","author":"A Barnier","year":"2009","unstructured":"Barnier A, Frachon I, Dewilde J, Gut-Gobert C, Jobic Y, Leroyer C (2009) Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy. Eur Respir J 34:277\u2013278","journal-title":"Eur Respir J"},{"key":"8265_CR58","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1128\/JVI.71.12.9764-9769.1997","volume":"71","author":"RC Desrosiers","year":"1997","unstructured":"Desrosiers RC, Sasseville VG, Czajak SC et al (1997) A herpesvirus of rhesus monkeys related to the human Kaposi\u2019s sarcoma-associated herpesvirus. J Virol 71:9764\u20139769","journal-title":"J Virol"},{"key":"8265_CR59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","volume":"349","author":"CD Cool","year":"2003","unstructured":"Cool CD, Rai PR, Yeager ME et al (2003) Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 349:1113\u20131122","journal-title":"N Engl J Med"},{"key":"8265_CR60","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.200504-546OC","volume":"172","author":"C Henke-Gendo","year":"2005","unstructured":"Henke-Gendo C, Mengel M, Hoeper MM, Alkharsah K, Schulz TF (2005) Absence of Kaposi\u2019s sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 172:1581\u20131585","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000097495","volume":"75","author":"D Bendayan","year":"2008","unstructured":"Bendayan D, Sarid R, Cohen A, Shitrit D, Shechtman I, Kramer MR (2008) Absence of human herpesvirus 8 DNA sequences in lung biopsies from Israeli patients with pulmonary arterial hypertension. Respiration 75:155\u2013157","journal-title":"Respiration"},{"key":"8265_CR62","doi-asserted-by":"crossref","unstructured":"Valmary S, Dorfmuller P, Montani D, Humbert M, Brousset P, Degano B (2011) Human gamma-herpesviruses EBV and HHV-8 are not detected in the lungs of patients with severe pulmonary arterial hypertension. Chest (in press)","DOI":"10.1378\/chest.10-1200"},{"key":"8265_CR63","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1378\/chest.10-0048","volume":"137","author":"BB Graham","year":"2010","unstructured":"Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137:20S\u201329S","journal-title":"Chest"},{"key":"8265_CR64","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.108.803221","volume":"119","author":"M Lapa","year":"2009","unstructured":"Lapa M, Dias B, Jardim C et al (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518\u20131523","journal-title":"Circulation"},{"key":"8265_CR65","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1055\/s-0029-1233307","volume":"30","author":"RM Tuder","year":"2009","unstructured":"Tuder RM (2009) Pathology of pulmonary arterial hypertension. Semin Respir Crit Care Med 30:376\u2013385","journal-title":"Semin Respir Crit Care Med"},{"key":"8265_CR66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.03.065","volume":"56","author":"CJ Santos Fernandes dos","year":"2010","unstructured":"dos Santos Fernandes CJ, Jardim CV, Hovnanian A et al (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715\u2013720","journal-title":"J Am Coll Cardiol"},{"key":"8265_CR67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1164\/rccm.200903-0355OC","volume":"181","author":"A Crosby","year":"2010","unstructured":"Crosby A, Jones FM, Southwood M et al (2010) Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med 181:279\u201388","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR68","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.ppat.0030052","volume":"3","author":"TC Freitas","year":"2007","unstructured":"Freitas TC, Jung E, Pearce EJ (2007) TGF-beta signaling controls embryo development in the parasitic flatworm Schistosoma mansoni. PLoS Pathog 3:e52","journal-title":"PLoS Pathog"},{"key":"8265_CR69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1183\/09031936.05.00112105","volume":"26","author":"L Mouthon","year":"2005","unstructured":"Mouthon L, Guillevin L, Humbert M (2005) Pulmonary arterial hypertension: an autoimmune disease? Eur Respir J 26:986\u2013988","journal-title":"Eur Respir J"},{"key":"8265_CR70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1164\/ajrccm.155.1.9001324","volume":"155","author":"JH Morse","year":"1997","unstructured":"Morse JH, Barst RJ, Fotino M et al (1997) Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7. Am J Respir Crit Care Med 155:274\u2013278","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.2000.01320.x","volume":"121","author":"B Grigolo","year":"2000","unstructured":"Grigolo B, Mazzetti I, Meliconi R et al (2000) Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35. Clin Exp Immunol 121:539\u2013543","journal-title":"Clin Exp Immunol"},{"key":"8265_CR72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/art.10914","volume":"49","author":"DB Ulanet","year":"2003","unstructured":"Ulanet DB, Wigley FM, Gelber AC, Rosen A (2003) Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Arthritis Rheum 49:85\u201392","journal-title":"Arthritis Rheum"},{"key":"8265_CR73","first-page":"462","volume":"25","author":"VS Negi","year":"1998","unstructured":"Negi VS, Tripathy NK, Misra R, Nityanand S (1998) Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 25:462\u2013466","journal-title":"J Rheumatol"},{"key":"8265_CR74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","volume":"97","author":"D Carvalho","year":"1996","unstructured":"Carvalho D, Savage CO, Black CM, Pearson JD (1996) IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 97:111\u2013119","journal-title":"J Clin Invest"},{"key":"8265_CR75","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1172\/JCI2261","volume":"101","author":"A Bordron","year":"1998","unstructured":"Bordron A, Dueymes M, Levy Y et al (1998) The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 101:2029\u20132035","journal-title":"J Clin Invest"},{"key":"8265_CR76","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1183\/09031936.00164209","volume":"35","author":"SJ Arends","year":"2010","unstructured":"Arends SJ, Damoiseaux J, Duijvestijn A et al (2010) Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension. Eur Respir J 35:923\u2013925","journal-title":"Eur Respir J"},{"key":"8265_CR77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1001-9294(10)60016-8","volume":"25","author":"MT Li","year":"2010","unstructured":"Li MT, Ai J, Tian Z et al (2010) Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chin Med Sci J 25:27\u201331","journal-title":"Chin Med Sci J"},{"key":"8265_CR78","unstructured":"Arends SJ, Damoiseaux J, Duijvestijn A, et al (2010) Functional heterogeinity of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension. In: 7th International Congress on Autoimmunity, Ljubljana, Slovenia."},{"key":"8265_CR79","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","volume":"46","author":"C Chizzolini","year":"2002","unstructured":"Chizzolini C, Raschi E, Rezzonico R et al (2002) Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 46:1602\u20131613","journal-title":"Arthritis Rheum"},{"key":"8265_CR80","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS, Santillo M, Bevilacqua F et al (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667\u20132676","journal-title":"N Engl J Med"},{"key":"8265_CR81","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","volume":"60","author":"JF Classen","year":"2009","unstructured":"Classen JF, Henrohn D, Rorsman F et al (2009) Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum 60:1137\u20131144","journal-title":"Arthritis Rheum"},{"key":"8265_CR82","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","volume":"60","author":"N Loizos","year":"2009","unstructured":"Loizos N, Lariccia L, Weiner J et al (2009) Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 60:1145\u20131151","journal-title":"Arthritis Rheum"},{"key":"8265_CR83","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/rheumatology\/kem241","volume":"46","author":"S Fineschi","year":"2007","unstructured":"Fineschi S, Cozzi F, Burger D, Dayer JM, Meroni PL, Chizzolini C (2007) Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts. Rheumatol Oxf 46:1779\u20131785","journal-title":"Rheumatol Oxf"},{"key":"8265_CR84","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1002\/art.24049","volume":"58","author":"S Fineschi","year":"2008","unstructured":"Fineschi S, Goffin L, Rezzonico R et al (2008) Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4. Arthritis Rheum 58:3913\u20133923","journal-title":"Arthritis Rheum"},{"key":"8265_CR85","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.21646","volume":"54","author":"J Henault","year":"2006","unstructured":"Henault J, Robitaille G, Senecal JL, Raymond Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 54:963\u2013973","journal-title":"Arthritis Rheum"},{"key":"8265_CR86","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1002\/art.24765","volume":"60","author":"G Robitaille","year":"2009","unstructured":"Robitaille G, Christin MS, Clement I, Senecal JL, Raymond Y (2009) Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells. Arthritis Rheum 60:2805\u20132816","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-011-8265-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8265-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T07:02:09Z","timestamp":1592377329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-011-8265-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,11]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["8265"],"URL":"https:\/\/doi.org\/10.1007\/s12016-011-8265-z","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,11]]}}}